Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ME | 23andMe Holding Co

Healthcare | Diagnostics & Research | USA | NASD

Index	RUT	P/E	-	EPS (ttm)	-0.72	Insider Own	38.95%	Shs Outstand	293.02M	Perf Week	-2.23%
Market Cap	461.95M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	-0.16%	Shs Float	288.46M	Perf Month	-14.98%
Income	-326.75M	PEG	-	EPS next Q	-0.14	Inst Own	23.29%	Short Float / Ratio	8.92% / 10.24	Perf Quarter	-44.13%
Sales	295.84M	P/S	1.56	EPS this Y	6.17%	Inst Trans	6.98%	Short Interest	25.73M	Perf Half Y	-56.55%
Book/sh	1.43	P/B	0.68	EPS next Y	6.66%	ROA	-33.80%	Target Price	4.50	Perf Year	-69.64%
Cash/sh	0.67	P/C	1.46	EPS next 5Y	-	ROE	-42.72%	52W Range	0.96 - 3.50	Perf YTD	-54.74%
Dividend	-	P/FCF	-	EPS past 5Y	-8.86%	ROI	-43.51%	52W High	-72.07%	Beta	1.38
Dividend %	-	Quick Ratio	2.87	Sales past 5Y	-21.82%	Gross Margin	35.32%	52W Low	1.83%	ATR	0.08
Employees	816	Current Ratio	2.97	Sales Q/Q	-5.66%	Oper. Margin	-114.75%	RSI (14)	38.37	Volatility	8.16% 7.37%
Optionable	Yes	Debt/Eq	0.12	EPS Q/Q	-12.87%	Profit Margin	-110.45%	Rel Volume	0.85	Prev Close	1.02
Shortable	Yes	LT Debt/Eq	0.11	Earnings	Aug 08 AMC	Payout	-	Avg Volume	2.51M	Price	0.98
Recom	1.67	SMA20	-7.38%	SMA50	-26.23%	SMA200	-50.44%	Volume	2,145,204	Change	-4.15%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-22	Initiated	Berenberg	Buy	$7
Sep-22-22	Initiated	Cowen	Outperform	$6
Nov-15-21	Downgrade	Citigroup	Buy → Neutral	$12 → $13
Aug-17-21	Initiated	Credit Suisse	Outperform	$13
Jul-12-21	Initiated	Citigroup	Buy	$14

Sep-27-23 04:05PM	23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancers (SITC) 2023 Annual Meeting (GlobeNewswire)
Sep-14-23 07:00AM	23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program (GlobeNewswire)
Sep-01-23 09:57AM	23andMe receives FDA approval to test for cancer variants (Yahoo Finance Video)
Aug-31-23 05:28PM	23andMe Granted New FDA Clearance to Report Additional BRCA Variants (GlobeNewswire)
Aug-25-23 05:10AM	Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe (Motley Fool) +5.71%
05:32AM	Loading…
Aug-22-23 05:32AM	23andMe: DNA testing kit company needs drug discovery (Financial Times) -9.65%
Aug-09-23 05:24PM	Why 23andMe Holding Stock Plummeted by 13% Today (Motley Fool) -12.93%
Aug-08-23 04:05PM	23andMe Reports FY2024 First Quarter Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	23andMe to Report FY2024 First Quarter Financial Results (GlobeNewswire)
Jul-20-23 09:23AM	23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin (GlobeNewswire)
Jun-26-23 03:00AM	Shake Shack Stock Blows Through the Roof. 23andMe Tumbles. (Barrons.com)
Jun-21-23 07:00AM	23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks (GlobeNewswire)
Jun-17-23 07:00AM	3 Gene Testing Stocks to Buy Before They Take Off (InvestorPlace)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey) -5.10%
May-26-23 08:00AM	Q4 2023 23andMe Holding Co. Earnings Call (Thomson Reuters StreetEvents)
04:05PM	Loading…
May-25-23 04:05PM	23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
May-23-23 09:53AM	Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics (Motley Fool)
May-19-23 06:40AM	Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich or Broke. (InvestorPlace)
May-16-23 10:59AM	Here's Why We're Not Too Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation (Simply Wall St.)
07:00AM	New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patients complete health picture (GlobeNewswire)
May-11-23 04:05PM	23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
May-09-23 07:00AM	23andMe Releases New Report Revealing Likelihood of Developing Lupus (GlobeNewswire)
May-08-23 07:00AM	Reza Afkhami Joins 23andMe as Chief Corporate Development Officer (GlobeNewswire)
May-01-23 08:20PM	Why the human genome could be health cares holy grail (Yahoo Finance Video)
11:54AM	23andMe CEO: We see more opportunities in DNA partnerships (Yahoo Finance)
Apr-30-23 09:38PM	2023 Milken Conference: the issues facing investors today (Yahoo Finance Video)
Apr-27-23 09:43AM	3 things to watch at next week's Milken Conference (Yahoo Finance Video)
Apr-19-23 08:57AM	23andMe Holding Co.'s (NASDAQ:ME) Share Price Could Signal Some Risk (Simply Wall St.)
Apr-14-23 04:05PM	23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 (GlobeNewswire)
Apr-11-23 07:00AM	Morehouse School of Medicine, Sickle Cell Foundation of Georgia and 23andMe Launch Sickle Cell Carrier Status Awareness Program (GlobeNewswire)
07:01AM	Loading…
Mar-29-23 07:01AM	23andMe Publishes Inaugural Environmental, Social and Governance Report (PR Newswire)
Mar-24-23 07:00AM	23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular Disease (GlobeNewswire)
Mar-23-23 06:22AM	23andMe Holding (NASDAQ:ME) shareholders have endured a 41% loss from investing in the stock a year ago (Simply Wall St.)
Mar-22-23 10:23AM	3 Key Ways That Artificial Intelligence Will Disrupt Biotech Stocks (Motley Fool)
Mar-17-23 10:15AM	WSJ. Magazine Celebrates Style & Tech in Silicon Valley (The Wall Street Journal)
Mar-14-23 04:30PM	23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2023 (GlobeNewswire)
Mar-09-23 10:07AM	AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023 (Motley Fool)
09:00AM	New 23andMe Surveys Find Most People and Doctors Agree that Genetic Testing Offers Promise for More Personalized Healthcare (GlobeNewswire)
Mar-02-23 07:30AM	2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise (Motley Fool)
Mar-01-23 07:00PM	Asias Richest Man Mukesh Ambani to Foray Into Genome Testing with $145 Kit (Bloomberg) -7.17%
Feb-28-23 10:23AM	2 High-Growth Stocks That Could Double Your Money in 5 Years or Less (Motley Fool)
07:00AM	23andMe Announces First Patient Dosed for the Phase 2a Portion of its Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 in Patients with Advanced Solid Malignancies (GlobeNewswire)
Feb-22-23 04:05PM	23andMe to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-10-23 06:12AM	This Genetics Stock Could Have Massive Long-Term Potential (Motley Fool)
05:45AM	23andMe Holding Third Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
Feb-08-23 04:50PM	23andMe stock jumps more than 12% on raised 2023 guidance (MarketWatch)
04:05PM	23andMe Reports FY2023 Third Quarter Financial Results (GlobeNewswire)
Feb-01-23 10:16AM	Top 25 Smartest Companies To Buy According To Hedge Funds (Insider Monkey)
Jan-26-23 04:05PM	23andMe to Report FY2023 Third Quarter Financial Results (GlobeNewswire)
Jan-25-23 07:30AM	3 Penny Stocks That Could Make You Filthy Rich (Motley Fool)
Jan-10-23 08:25AM	Institutional investors own a significant stake of 37% in 23andMe Holding Co. (NASDAQ:ME) (Simply Wall St.)
Dec-13-22 11:10AM	10 Penny Stocks That Can Grow Big in 2023 (Insider Monkey)
Dec-05-22 09:51AM	Dante Labs: Innovating Whole Genome Sequencing (Exec Edge) -8.07%
12:00AM	US companies face backlash for bypassing investors on top pay (Financial Times)
Dec-01-22 12:00PM	23andMe Survey Shows Majority of People Less Stressed About Their Health During This Holiday Season (GlobeNewswire) +6.23%
Nov-17-22 01:58PM	Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies (Insider Monkey)
Nov-15-22 12:04PM	Telehealth: Theres a real opportunity for investment, 23andMe founder says (Yahoo Finance Video)
Nov-07-22 04:01PM	23andMe Reports FY2023 Second Quarter Financial Results (GlobeNewswire)
08:00AM	23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancers (SITC) 2022 Annual Meeting (GlobeNewswire)
Oct-27-22 06:45AM	23andMe Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication (GlobeNewswire)
Oct-25-22 01:05PM	8 Undervalued Reddit Stocks to Buy Before Wall Street Catches On (InvestorPlace) +6.74%
Oct-24-22 04:05PM	23andMe to Report FY2023 Second Quarter Financial Results (GlobeNewswire)
Oct-21-22 10:15AM	2 Budding Growth Stocks That Could Turn $1,000 Into $10,000 in 8 Years (Motley Fool)
Oct-12-22 04:10PM	23andMe to Present at Upcoming Investor Conferences (GlobeNewswire) +5.78%
Oct-11-22 07:51AM	Shareholders in 23andMe Holding (NASDAQ:ME) are in the red if they invested a year ago (Simply Wall St.)
Oct-05-22 10:30AM	3 Reasons You Should (Still) Be Buying Growth Stocks Right Now (Motley Fool)
08:21AM	23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancers (SITC) 2022 Annual Meeting (GlobeNewswire)
Sep-19-22 06:45AM	Daniel Chu Joins 23andMe as Chief Product Officer (GlobeNewswire)
Sep-15-22 06:00AM	Influencers with Andy Serwer: Deb Liu (Yahoo Finance Video)
05:16AM	Ancestry CEO on 23andMe: I think their product is really incredible (Yahoo Finance Video)
Sep-07-22 06:39AM	One 23andMe Holding Co. (NASDAQ:ME) insider upped their stake in the previous year (Simply Wall St.)
Sep-02-22 06:22AM	2 Ex-SPACs I Wouldn't Touch Right Now (Motley Fool) -5.76%
Aug-30-22 02:48PM	Exact Sciences: Don't Deem It Guilty by Association (TheStreet.com)
Aug-25-22 12:10PM	Fulgent Genetics Seeks Post-Pandemic Growth (TheStreet.com) +5.18%
09:09AM	10 Stocks That Jumped After Jim Cramers Negative Call (Insider Monkey)
Aug-19-22 08:43AM	23andMe stock falls after company says CFO to depart (MarketWatch) -20.33%
Aug-16-22 09:03AM	Jim Cramer Recommends Selling These 10 Stocks in August (Insider Monkey)
Aug-11-22 02:58PM	Despite Some Big Losers, These Growth Stocks Are Keeping the Nasdaq Bull Market Going (Motley Fool) +6.11%
06:34AM	Earnings Release: Here's Why Analysts Cut Their 23andMe Holding Co. (NASDAQ:ME) Price Target To US$5.00 (Simply Wall St.)
Aug-08-22 04:05PM	23andMe Reports FY2023 First Quarter Financial Results (GlobeNewswire) +9.34%
01:31PM	Why 23andMe Stock Jumped Higher on Monday (Motley Fool)
Aug-03-22 08:15AM	Do Institutions Own 23andMe Holding Co. (NASDAQ:ME) Shares? (Simply Wall St.) +9.97%
Jul-25-22 04:05PM	23andMe to Report FY2023 First Quarter Financial Results (GlobeNewswire)
Jul-11-22 02:03PM	The Funded: These Sequoia portfolio company values took big hit after 2021 stock debuts (American City Business Journals) -7.84%
Jul-08-22 10:18AM	Market check: Stocks drift lower on strong jobs report (Yahoo Finance Video)
Jul-01-22 06:00AM	7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On (InvestorPlace)
Jun-17-22 03:27PM	The Funded: Grove Collaborative soars 68% in stock debut after it completed the Bay Area's 8th SPAC merger of 2022 (American City Business Journals) +6.36%
Jun-08-22 09:03PM	23andMe has officially moved and downsized its HQ (American City Business Journals)
Jun-02-22 07:32AM	Women, people with high cholesterol have higher risk for long COVID, according to 23andMe (MarketWatch)
May-27-22 02:28PM	Why 23andMe Stock Was Lagging the Market Today (Motley Fool)
May-26-22 06:51PM	23andMe stock falls on widening loss (MarketWatch)
04:05PM	23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
11:13AM	10 Stocks To Sell Now According To David Einhorns Greenlight Capital (Insider Monkey)
May-24-22 06:30AM	Quarterhill Appoints John Karnes as CFO (CNW Group) -5.08%
May-12-22 04:10PM	23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results (GlobeNewswire) +11.50%
May-03-22 03:04PM	Investors one-year losses grow to 69% as the stock sheds US$72m this past week (Simply Wall St.)
Apr-29-22 03:35PM	23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People (Motley Fool)
Apr-10-22 06:00AM	This Exciting Biotech Stock Could Be Your Next 10-Bagger (Motley Fool)
Apr-06-22 06:11PM	Top 10 Stocks Billionaire David Einhorn Just Added to His Portfolio (Insider Monkey) -5.29%
10:19AM	Bullish insiders at Moneta Gold Inc. (TSE:ME) loaded up on CA$641k of stock earlier this year (Simply Wall St.)

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIBBS KATHY L	Chief Administrative Officer	Sep 21	Option Exercise	0.42	38,548	16,190	1,323,524	Sep 25 04:00 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 21	Sale	1.00	38,548	38,583	1,284,976	Sep 25 04:00 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 07	Option Exercise	0.42	40,894	17,175	299,880	Sep 11 04:04 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 07	Sale	1.06	40,894	43,483	258,984	Sep 11 04:04 PM
Richards William G	Head of Therapeutics Discovery	Sep 05	Sale	1.08	2,538	2,741	211,041	Sep 06 05:01 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 24	Option Exercise	0.42	40,894	17,175	293,406	Aug 25 04:57 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 24	Sale	1.05	40,894	43,119	252,512	Aug 25 04:57 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 15	Option Exercise	0.42	40,894	17,175	298,034	Aug 16 04:51 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 15	Sale	1.32	40,894	53,939	257,140	Aug 16 04:51 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 27	Option Exercise	0.42	40,894	17,175	298,034	Jul 31 04:23 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 27	Sale	1.89	40,894	77,257	257,140	Jul 31 04:23 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 13	Option Exercise	0.42	40,894	17,175	298,034	Jul 14 04:33 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 13	Sale	1.82	40,894	74,239	257,140	Jul 14 04:33 PM
HIBBS KATHY L	Chief Administrative Officer	Jun 29	Option Exercise	0.42	40,894	17,175	298,034	Jun 30 04:22 PM
HIBBS KATHY L	Chief Administrative Officer	Jun 29	Sale	1.72	40,894	70,432	257,140	Jun 30 04:22 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 05	Sale	3.25	26,259	85,342	235,829	Dec 06 05:44 PM
SCHELLER RICHARD H	Director	Nov 11	Sale	3.24	18,421	59,684	72,388	Nov 14 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ME | 23andMe Holding Co

Upgrade your FINVIZ experience